Two companies have recently gained approval from the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) to sell their cell-cultured meat products in the US. This marks a significant milestone for the alternative protein industry, particularly for cell-cultured products.
Having fulfilled all regulatory requirements, including obtaining a “No Question” letter from the FDA, approval for product labels from the USDA, and the USDA Grant of Inspection (GOI), these companies are now one step closer to bringing their cultivated meat products to the market, signifying a historic achievement for both of them.
The production of meat cultivated from animal cells offers a potential solution to current environmental sustainability challenges. Studies indicate that these alternative protein production methods can reduce the environmental carbon footprint, improve resource efficiency, decrease antibiotic use, and diversify protein sources.
Considering the implications of these recent approvals and the future of the cultured meat industry, there is a need for harmonized and minimal analytical methods to ensure the safety, quality, and acceptability of these products.
Validated official methods and authentic reference materials are essential as these products enter the market. Mérieux NutriSciences (MXNS), a partner for traditional and innovative food producers, is prepared to contribute to this industry’s progress. They aim to collaborate with stakeholders to address consumer acceptance and regulatory compliance challenges.
Mérieux NutriSciences is the parent company of Biofortis Research. While Biofortis works solely from within the United States, Mérieux NutriSciences conducts research, development, and services on a global scale.
Mérieux NutriSciences offers a range of capabilities, including nutrition and sensory profiling, process optimization, and shelf-life extension. They have initiated collaborations with prominent analytical organizations like the Association of Official Analytical Collaboration (AOAC International).
Furthermore, Mérieux NutriSciences is organizing a scientific session and discussion at AOAC’s annual meeting and exposition in New Orleans on August 30 to further these efforts. Their goal is to develop validated official analysis methods in partnership with key stakeholders to ensure the safety and acceptability of these novel products.
With their expertise in analytical chemistry and microbiology, Mérieux NutriSciences is committed to producing high-quality and safe products for their customers. Their unwavering dedication to customer safety drives their mission to propel this industry toward a promising future.
Biofortis is dedicated to protecting consumer health throughout the world by delivering a wide range of testing and consultancy services to the food, supplement, and nutrition industries. Biofortis supports this mission in two ways—through clinical trials and sensory and consumer insights testing. We specialize in clinical research targeting foods, ingredients, and dietary supplements that affect body structures, function, and overall health. Contact us with any clinical trial or scientific consulting needs.
Original article posted by Mérieux NutriSciences.